Hubbry Logo
Perinatal mortalityPerinatal mortalityMain
Open search
Perinatal mortality
Community hub
Perinatal mortality
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Perinatal mortality
Perinatal mortality
Perinatal mortality
View on Wikipedia
from Wikipedia
Perinatal mortality
Other namesPerinatal death
Infant, neonatal, and postneonatal mortality rates: United States, 1940–2005
SpecialtyPublic health

Perinatal mortality (PNM) is the death of a fetus or neonate and is the basis to calculate the perinatal mortality rate.[1] Perinatal means "relating to the period starting a few weeks before birth and including the birth and a few weeks after birth."[2]

Variations in the precise definition of the perinatal mortality exist, specifically concerning the issue of inclusion or exclusion of early fetal and late neonatal fatalities. The World Health Organization defines perinatal mortality as the "number of stillbirths and deaths in the first week of life per 1,000 total births, the perinatal period commences at 22 completed weeks (154 days) of gestation,[3] and ends seven completed days after birth",[4] but other definitions have been used.[5]

The UK figure is about 8 per 1,000 and varies markedly by social class with the highest rates seen in Asian women. Globally, an estimated 2.6 million neonates died in 2013 before the first month of age down from 4.5 million in 1990.[6]

Causes

[edit]
Further information: Preterm birth § Specific risks for the preterm neonate

Preterm birth is the most common cause of perinatal mortality, causing almost 30 percent of neonatal deaths.[7] Infant respiratory distress syndrome, in turn, is the leading cause of death in preterm infants, affecting about 1% of newborn infants.[8] Birth defects cause about 21 percent of neonatal death.[7]

Some major causes of perinatal mortality rate is:

  • Maternal diseases
  • Pelvic diseases; endometriosis, ovarian tumor
  • Anatomical defects; Uterine, Cervical anomalies
  • Endocrine imbalance
  • Blood incompatibilities
  • Malnutrition
  • Toxemias of pregnancy
  • APH
  • Congenital defects
  • Advanced maternal age

Fetal mortality

[edit]

Fetal mortality refers to stillbirths or fetal death.[9] It encompasses any death of a fetus after 20 weeks of gestation or 500 gm. In some definitions of the PNM early fetal mortality (week 20–27 gestation) is not included, and the PNM may only include late fetal death and neonatal death. Fetal death can also be divided into death prior to labor, antenatal (antepartum) death, and death during labor, intranatal (intrapartum) death.

Neonatal mortality

[edit]

Neonatal mortality refers to death of a live-born baby within the first 28 days of life. Early neonatal mortality refers to the death of a live-born baby within the first seven days of life, while late neonatal mortality refers to death after 7 days until before 28 days. Some definitions of the PNM include only the early neonatal mortality. Neonatal mortality is affected by the quality of in-hospital care for the neonate. Neonatal mortality and postneonatal mortality (covering the remaining 11 months of the first year of life) are reflected in the infant mortality rate.

Perinatal mortality rate

[edit]
Top ten countries
with the highest perinatal mortality rates – 2012[10][11][12]
Rank Country PNMR Rank Country PNMR
1  Pakistan 40.7 6  Afghanistan 29.0
2  Nigeria 32.7 7  Bangladesh 28.9
3  Sierra Leone 30.8 8  Democratic Republic of the Congo 28.3
4  Somalia 29.7 9  Lesotho 27.5
5  Guinea-Bissau 29.4 10  Angola 27.4
As per 2014 "Save the Children" report for intrapartum stillbirths
and neonatal deaths on first day of birth (per 1,000 total births)

The PNMR refers to the number of perinatal deaths per 1,000 total births. It is usually reported on an annual basis.[13] It is a major marker to assess the quality of health care delivery. Comparisons between different rates may be hampered by varying definitions, registration bias, and differences in the underlying risks of the populations.

PNMRs vary widely and may be below 10 for certain developed countries and more than 10 times higher in developing countries.[14] The WHO has not published contemporary data.

Effects of neonatal nutrition on neonatal mortality

[edit]

Probiotic supplementation of preterm and low birthweight babies during their first month of life can reduce the risk of blood infections, bowel sickness and death in low- and middle-income settings. However, supplementing with Vitamin A does not reduce the risk of death and increases the risk of bulging fontanelle, which may cause brain damage.[15]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Perinatal mortality

View on Grokipedia
from Grokipedia

Perinatal mortality encompasses stillbirths, defined as fetal deaths occurring after 24 weeks of , and early neonatal deaths within the first seven days of , typically measured as the number of such events per 1,000 total births (live births plus stillbirths).00169-0/fulltext) This metric serves as a fundamental indicator of the quality and accessibility of maternal, fetal, and newborn care systems, highlighting vulnerabilities in outcomes from late through the immediate postnatal period. The primary causes of perinatal mortality, grounded in empirical observations from clinical and epidemiological studies, include complications, intrapartum , and infections, which account for the majority of cases across diverse settings. These factors often stem from causal chains involving conditions, inadequate antenatal monitoring, and limited intrapartum interventions, with prematurity alone implicated in up to 48% of early neonatal deaths in some cohorts. Globally, rates exhibit stark disparities, remaining low in high-income nations—such as approximately 8.4 per 1,000 in 2023—while elevated in low-resource regions due to systemic gaps in healthcare infrastructure and socioeconomic determinants like and . Trends indicate gradual declines attributable to advancements in obstetric practices and , yet progress has stagnated in certain areas, underscoring the need for targeted interventions addressing root biological and environmental risks rather than superficial correlates. In resource-constrained environments, underreporting and inconsistent definitions further complicate accurate assessment, emphasizing the importance of standardized, data-driven for and policy formulation.00125-0/fulltext)

Definition and Classification

Core Definitions

Perinatal mortality is defined as the aggregate of stillbirths (fetal deaths occurring after a viability threshold) and early neonatal deaths (live-born infants dying within the first week of ). This metric captures mortality risks clustered around the birth process, reflecting vulnerabilities in late , delivery, and immediate postnatal adaptation. A constitutes the intrauterine death of a at or after 22 completed weeks of (or equivalent fetal weight of approximately 500 grams), prior to complete expulsion or extraction from the mother, irrespective of the duration of pregnancy once viability is reached. Early neonatal death is the demise of a live-born neonate from birth through the first six completed days of life. The perinatal period relevant to these definitions spans from 22 completed weeks of to seven completed days postpartum, encompassing antepartum, intrapartum, and early postnatal phases. The perinatal mortality rate is computed as the sum of stillbirths and early neonatal deaths divided by the total number of births (live births plus stillbirths of the defined gestational threshold), multiplied by 1,000, yielding deaths per 1,000 births. This denominator accounts for the exposed population at risk, though exact gestational cutoffs for inclusion (e.g., 20 versus 28 weeks) can vary by jurisdiction or reporting standard.

International Variations and Standards

The (WHO) defines perinatal mortality as the aggregate of stillbirths—fetal deaths occurring after 22 completed weeks of gestation or with a of at least 500 grams—and early neonatal deaths within the first seven days of life, typically expressed as a rate per 1,000 total births (live births plus stillbirths). This standard aims to facilitate global monitoring and comparison, though WHO acknowledges flexibility in using thresholds of 22 weeks or criteria when precise data are unavailable. For cause-of-death attribution, WHO endorses the to Perinatal Mortality (ICD-PM), a simplified tool developed in 2015 to standardize coding of perinatal deaths across resource-limited settings, categorizing causes into fetal, maternal, and placental factors while emphasizing avoidable contributors like intrapartum complications. International standards have evolved with the adoption of in 2022, which provides updated guidance for reporting stillbirths and perinatal deaths, recommending gestational age thresholds of at least 22 weeks for stillbirths and integrating perinatal mortality into broader maternal and child health surveillance frameworks to improve and comparability. The International Federation of Gynecology and Obstetrics (FIGO) aligns with this by advocating perinatal mortality rates calculated from stillbirths at or after 28 weeks plus neonatal deaths from day 0 to 6 for births at or after 28 weeks, divided by total such births and multiplied by 1,000, to support clinical audits and policy interventions. These standards prioritize empirical registration of all fetal and neonatal losses meeting criteria, irrespective of or viability perceptions, to capture causal pathways like or without underreporting due to cultural or administrative biases. Despite these efforts, definitional variations persist across countries, undermining direct comparisons; for instance, many high-income nations like those in use a 24-week threshold for registration, while others, including parts of the under CDC Definition I, apply 28 weeks or more, excluding earlier losses and yielding artificially lower rates. In contrast, broader definitions incorporating 20-week fetal deaths (as in some U.S. contexts under Definition III or certain low-resource settings) inflate rates by including spontaneous abortions misclassified as perinatal events, while pragmatic registration practices—such as mandatory reporting only for live births or institutionally delivered cases—further distort data in regions with high home births or incomplete civil registries. These discrepancies, often unadjusted in national statistics, can international rankings; a 2017 analysis highlighted how differing inclusion of multiple births, congenital anomalies, or termination-of-pregnancy outcomes leads to perinatal mortality rate variances of up to 50% between ostensibly comparable high-income countries. Efforts to mitigate variations include WHO's Perinatal Death Surveillance and Response initiatives, which promote standardized audits in low- and middle-income countries to link causes to interventions, revealing systemic underreporting where cultural stigma or weak vital registration systems exclude community-level deaths. Peer-reviewed evaluations emphasize that true comparability requires harmonized cutoffs (ideally 22-28 weeks) and total-birth denominators, as partial live-birth denominators overestimate survival in nations with selective reporting. Ongoing challenges, such as inconsistent application of ICD-PM globally—with adoption limited to about 20 countries as of 2022—underscore the need for causal realism in interpreting rates, prioritizing data from robust registries over survey-based estimates prone to .

Epidemiology

Global Burden and Rates

The global burden of perinatal mortality, encompassing stillbirths (fetal deaths at or after 28 weeks of ) and early neonatal deaths (within the first 7 days of life), results in millions of losses annually, predominantly in low- and middle-income countries. In 2023, estimated 1.9 million stillbirths worldwide, equivalent to one every 17 seconds and a rate of 14.3 stillbirths per 1,000 total births (live births plus stillbirths). This figure reflects minimal progress, with the stillbirth rate declining only 5.9% since 2000, far slower than reductions in under-5 mortality. Neonatal deaths added 2.3 million cases in 2023, at a rate of 17 per 1,000 live births, accounting for roughly two-thirds of all under-5 deaths and with early neonatal deaths comprising the majority (approximately 75%) due to complications like and infections. Combining these components yields an approximate global perinatal mortality rate of 30-32 per 1,000 births, though precise aggregation varies by source owing to differences in early neonatal data capture and denominator definitions (total births versus live births).00125-0/fulltext) Disparities are stark across regions, driven by inequities in healthcare access, with over 80% of perinatal deaths concentrated in and . In , neonatal mortality rates exceed 25 per 1,000 live births, while stillbirth rates surpass 20 per 1,000 total births in some areas; follows closely with rates around 20-25 for both components. High-income regions, by contrast, report perinatal rates below 5 per 1,000, highlighting the role of systemic factors like , conflict, and inadequate intrapartum care in perpetuating high burdens. These estimates, derived from vital registration, household surveys, and modeling by bodies like the UN Inter-agency Group for Estimation, underscore underreporting in resource-poor settings, where data quality remains a challenge.
RegionStillbirth Rate (per 1,000 total births, ~2023)Neonatal Mortality Rate (per 1,000 live births, 2023)
>2025+
15-2020-25
Global Average14.317
High-Income Countries<5<3
Overall, perinatal mortality contributes substantially to the sustainable development goals' shortfall on child survival, with preventable causes amenable to interventions like improved maternal nutrition and emergency obstetric services unaddressed in high-burden areas. Perinatal mortality rates have declined substantially in high-income countries over the past century, driven by improvements in antenatal care, obstetric interventions, and neonatal resuscitation techniques. In the United States, for instance, rates fell by approximately 30% from 1990 to 2011, stabilizing thereafter before a modest 4% reduction from 2017 to 2019. By 2021, the U.S. perinatal mortality rate stood at 5.54 per 1,000 live births plus fetal deaths (using a definition including fetal deaths at 20 weeks or more gestation and early neonatal deaths), though broader definitions incorporating earlier gestations yield higher figures around 8 per 1,000. Similar trajectories occurred in other developed nations, where rates dropped from over 40 per 1,000 births in the mid-20th century to single digits by the late 20th century, reflecting causal factors like widespread access to cesarean sections and infection control. Globally, progress has been uneven and slower, with perinatal mortality remaining elevated in low- and middle-income countries due to persistent gaps in healthcare infrastructure and emergency obstetric services. Stillbirth rates, a key component of perinatal mortality, decreased from an estimated 24 per 1,000 total births in 2000 to 13.9 per 1,000 in 2021 (for gestations of 28 weeks or later), equating to about 1.9 million stillbirths annually. Early neonatal mortality, the other primary element, paralleled neonatal trends, declining from roughly 25 per 1,000 live births in 1990 to 17 per 1,000 by 2023, though annual reductions have accelerated post-2000 in most regions. Overall global perinatal rates, combining these, hovered around 30–40 per 1,000 births in the early 2000s and have seen limited further decline, with over 90% of the burden concentrated in resource-limited settings where intrapartum complications predominate. Recent trends indicate stagnation or reversal in some areas amid disruptions like the COVID-19 pandemic, which temporarily elevated rates in high-income countries including the U.S., where perinatal mortality rose nonsignificantly to 8.36 per 1,000 in 2023 from 8.27 in 2022. In developing regions, stillbirth rates have shown minimal improvement since 2012, with annual declines near zero, underscoring failures in scaling interventions like improved monitoring and timely delivery. Despite these challenges, targeted efforts in select low-income countries have yielded reductions, highlighting the potential for causal interventions in high-burden contexts.

Geographic and Demographic Variations

Perinatal mortality rates exhibit stark geographic disparities, with low- and lower-middle-income countries bearing the heaviest burden. In high-income countries, rates typically range from 3 to 6 per 1,000 births, reflecting advanced healthcare access, prenatal screening, and obstetric interventions. In contrast, many low-income countries report rates exceeding 40 per 1,000 births, driven by limited antenatal care, infectious diseases, and malnutrition. Sub-Saharan Africa and account for approximately three-quarters of global stillbirths, which constitute a major component of perinatal deaths; in 2023, sub-Saharan Africa alone contributed nearly 45% of the world's 1.9 million stillbirths occurring at or after 28 weeks' gestation. Neonatal mortality, the other key element, follows a similar pattern: regional rates in sub-Saharan Africa reached about 27 per 1,000 live births in recent estimates, compared to 4-5 in high-income regions. Country-level data underscore these regional trends. Nations such as Pakistan, Nigeria, and the Democratic Republic of the Congo consistently rank among the highest, with combined stillbirth and early neonatal rates often surpassing 50 per 1,000 births due to factors like poor infrastructure and high maternal anemia prevalence. For instance, Pakistan's neonatal mortality rate stood at around 42 per 1,000 live births in 2021 data, augmented by stillbirth rates over 20 per 1,000. In Europe and North America, rates are markedly lower; the United States reported a perinatal mortality rate of approximately 5.6 per 1,000 in 2021, though this exceeds peers like Japan or Finland at under 3 per 1,000. These variations persist despite global declines, with progress slowest in fragile states affected by conflict or weak governance. Demographic factors further modulate perinatal risks within and across regions. Maternal age shows a U-shaped association: rates are elevated among adolescents under 20 (e.g., 7 per 1,000 in U.S. data for 2021) and women over 35 (rising to 6-8 per 1,000), linked to physiological vulnerabilities like preterm labor or chromosomal anomalies, independent of socioeconomic confounders. By race and ethnicity, non-Hispanic Black women in the United States experience roughly twice the perinatal mortality risk of White women (e.g., infant mortality components at 10-12 per 1,000 vs. 4-5), even after adjusting for education and income, pointing to unmeasured factors such as differential access to quality care or underlying health disparities. Similar patterns emerge globally: African-origin women in Europe face 1.7-fold higher fetal mortality odds compared to native populations. Socioeconomic status exhibits an inverse gradient, with higher household income correlating to 20-30% lower perinatal risks in cohort studies, attributable to better nutrition, timely interventions, and environmental exposures. In low-resource settings, rural residence amplifies these effects, often doubling rates relative to urban areas due to distance from facilities. Ethnic minorities in high-income countries, such as South Asian groups, show elevated risks (1.8-fold for stillbirths), potentially tied to consanguinity or cultural delays in seeking care, though data emphasize the interplay of biology and environment over singular causes.
Region/GroupApproximate PNMR (per 1,000 births)Key Source
High-income countries3-6CDC/WHO estimates
Sub-Saharan Africa40-60UNICEF stillbirth/neonatal data
South Asia30-50Regional aggregates
U.S. Black ethnicity8-10 (adjusted components)KFF/CDC
Maternal age <20 or >356-8U.S. vital statistics

Etiology and Pathophysiology

Fetal and Placental Abnormalities

Fetal abnormalities, encompassing congenital malformations and genetic anomalies, represent a significant of perinatal mortality, particularly through mechanisms incompatible with extrauterine life or leading to intrauterine demise. Structural defects such as neural tube defects (e.g., and ), congenital heart anomalies, and chromosomal aberrations (e.g., trisomies 13, 18, and 21) are among the most lethal, often resulting in or early neonatal death due to , cardiac insufficiency, or multiorgan dysfunction. In population-based studies, congenital anomalies account for approximately 17-33% of perinatal deaths, with lethal malformations identified in up to 51% of cases within affected cohorts. These anomalies arise primarily from disruptions in embryogenesis, influenced by genetic factors, teratogens, or multifactorial inheritance, culminating in fetal demise when vital organ systems fail to sustain viability. Placental abnormalities contribute to perinatal mortality via impaired maternofetal exchange, leading to chronic hypoxia, acidosis, and growth restriction. Placental , characterized by inadequate vascular remodeling of uterine spiral arteries, reduces oxygen and nutrient delivery, often manifesting as fetal growth restriction (FGR) and culminating in from hypoxic-ischemic injury. Pathological findings such as , abruption, or villous immaturity are prevalent in 11-84% of cases, with uteroplacental vascular lesions directly implicated in fetal death through acute or subacute . In detailed classifications, placental accounts for about 23% of stillbirths, often coexisting with fetal anomalies or maternal conditions that exacerbate deficits. The interplay between fetal and placental pathologies amplifies risk; for instance, fetal malformations may secondarily impair placental function through altered vascular demands, while primary placental defects can induce fetal stress responses leading to demise. Autopsy and histopathological evaluations remain essential for attribution, revealing that up to 65% of unexplained stillbirths harbor subtle placental lesions upon scrutiny. Early detection via ultrasonography or biomarkers can mitigate some outcomes, though many lethal anomalies evade antenatal diagnosis.

Maternal Physiological and Pathological Factors

Maternal advanced age, typically defined as 35 years or older, is associated with increased perinatal mortality risk, with meta-analyses indicating an of 1.58 (95% CI: 1.25-2.00) for women aged 35 and above compared to younger counterparts. This risk escalates further for ages 40 and older, with odds ratios reaching 2.57 (95% CI: 1.57-4.22) for antenatal deaths, attributed to higher incidences of chromosomal anomalies, , and preterm delivery. Maternal , measured by pre-pregnancy (BMI) ≥30 kg/m², correlates with elevated infant mortality, showing a pooled of 1.42 (95% CI: 1.25-1.62) versus normal BMI, with risks amplifying incrementally per 5-unit BMI increase due to complications like macrosomia, , and . Grand multiparity (≥5 previous births) also heightens vulnerability, as evidenced in cohort studies where it predicts perinatal loss through mechanisms including and exhaustion of reproductive reserves, though exact odds vary by population. Pathological conditions such as hypertensive disorders, particularly , substantially contribute to perinatal mortality, accounting for 1 in 10 to 1 in 4 such deaths globally via placental hypoperfusion, , and . elevates fetal death risk markedly in preterm gestations, with relative risks exceeding 10-fold in affected cases before 34 weeks, underscoring its role in abruptio placentae and . Gestational diabetes mellitus shows inconsistent direct links to or neonatal death after glycemic control, with some analyses reporting no significant increase (relative risk 0.75 for diet-controlled cases), though pregestational diabetes doubles severe neonatal morbidity and mortality risks through hyperglycemia-induced fetal macrosomia and metabolic derangements. Maternal infections, including and , independently and synergistically amplify perinatal mortality; dual infection raises risks of maternal , low birth weight, and early infant death, with odds ratios for perinatal loss up to 3-4 times higher in co-infected pregnancies due to placental sequestration and immune suppression. In high-burden regions, malaria alone associates with perinatal mortality rates 2-5 times baseline via fetal parasitemia and , while exacerbates vertical transmission and prematurity. Other pathologies like severe (hemoglobin <7 g/dL) and underlying cardiac disease further compound risks by impairing oxygen delivery to the , though data emphasize treatable causes predominate in low-resource settings. These factors interact with socioeconomic determinants, but causal pathways center on uteroplacental insufficiency and , as confirmed in histopathological reviews. Intrapartum-related perinatal mortality encompasses fetal deaths occurring during labor and delivery, as well as early neonatal deaths attributable to events in this period, primarily driven by acute interruptions in fetal oxygenation and circulatory compromise. Hypoxia accounts for approximately 78% of intrapartum stillbirths, often resulting from exacerbated by labor dynamics or mechanical obstructions.00163-4/fulltext) These mechanisms differ from antepartum causes by their temporal proximity to delivery, where dynamic factors like amplify underlying vulnerabilities, leading to rapid in fetal reserve. A primary mechanism is birth asphyxia, characterized by failure to initiate or sustain effective respiration at birth due to intrapartum hypoxia, contributing to 23-29% of global neonatal deaths and a substantial fraction of perinatal losses in resource-limited settings. arises from prolonged or obstructed labor, where or fetal malposition impedes descent, causing sustained compression of the or reduced placental blood flow; for instance, cord prolapse or entanglement can precipitate acute ischemia within minutes. or abruption during active labor further compromises , with studies identifying these as key precipitants in up to 36% of unexpected intrapartum fetal deaths when excluding malformations. Delivery trauma represents another critical pathway, particularly in operative births or malpresentations, where excessive force during , application, or breech delivery inflicts direct injury, such as or damage, elevating early neonatal mortality risk. , occurring in 0.2-3% of vaginal deliveries, exemplifies this by compressing the umbilical against the maternal pelvis, leading to hypoxia and potential neurological devastation if unresolved promptly; unresolved cases correlate with 10-20% perinatal loss rates in affected cohorts. In settings with delayed intervention, secondary from prolonged membrane rupture or chorioamnionitis during labor compounds these risks, transitioning mechanical insults into inflammatory cascades that impair neonatal . Overall, these mechanisms underscore the interplay of fetal with labor , where deviations from optimal progression—often measurable via fetal monitoring—signal impending demise if unmitigated.

Risk Factors

Biological and Demographic Risks

Maternal age at delivery is a key demographic for perinatal mortality, with elevated rates observed at both extremes. Adolescents under 20 years face higher perinatal mortality rates, approximately 6.97 per 1,000 births in 2021, compared to 4.98 per 1,000 for mothers aged 30–34, primarily due to increased and . over 35 similarly increases risk, with rates rising progressively; for instance, women over 40 experience heightened early neonatal mortality linked to chromosomal abnormalities and . A maternal age below 29 or above 40 years correlates with relatively higher early neonatal mortality , independent of other confounders. Parity influences perinatal outcomes, where both primiparity and high parity (grand multiparity, typically five or more births) elevate risks. Short interpregnancy intervals under two years are associated with increased perinatal mortality, often through mechanisms like maternal nutrient depletion and uterine overdistension. Primiparous women exhibit higher rates due to immature reproductive physiology and complications such as preeclampsia. Racial and ethnic demographics show persistent disparities in perinatal mortality. Non-Hispanic Black infants in the United States face approximately twice the compared to White infants, with perinatal components driven by higher preterm delivery and congenital anomalies; this disparity holds across maternal age groups. experience a 3.2-fold increased of maternal mortality contributing to perinatal loss, even after adjusting for socioeconomic factors, suggesting underlying biological and systemic elements. American Indian/Alaska Native, , and Native Hawaiian/Pacific Islander groups also show elevated neonatal death risks, with neonates facing up to three times the odds compared to White neonates in high-income settings. Ethnic variations in optimal for survival further indicate biological differences, as term mortality risks differ by maternal ethnicity beyond alone. Biological factors include fetal sex, with male infants exhibiting higher neonatal mortality rates across settings, attributed to greater vulnerability to prematurity and . Multiple gestations inherently double or triple perinatal mortality risks due to preterm labor and growth restriction. Pre-existing maternal conditions such as and , which have biological underpinnings, independently predict perinatal death through placental pathology and macrosomia or . Congenital anomalies account for a significant portion of cases, remaining a leading cause alongside prematurity.

Lifestyle and Behavioral Contributors

Maternal during substantially elevates the risk of perinatal mortality, with meta-analyses indicating dose-dependent increases in (odds ratio approximately 1.2–1.5), neonatal death, and overall perinatal death rates. Prenatal is linked to a 20–30% higher likelihood of and a 40% increase in , primarily through mechanisms such as , , and . Obesity in pregnant women, often stemming from sustained lifestyle patterns of caloric excess and sedentary behavior, is associated with heightened perinatal mortality risks. face a 42% increased of death compared to normal-weight counterparts, with adjusted perinatal death rates up to 55% higher, attributable to complications like , , and macrosomia leading to birth trauma. and categories show adjusted ratios of 1.22 and higher for perinatal mortality in large cohort studies. Prenatal alcohol exposure contributes to stillbirth risk, with heavy consumption linked to elevated odds independent of other factors, and combined use with tripling late-term stillbirth rates (up to 15 per 1,000 births versus 4 per 1,000 in unexposed pregnancies). Illicit drug use, including opioids and , correlates with increased perinatal mortality through , preterm delivery, and neonatal complications, with exposed infants showing up to 82% higher adjusted hazard ratios for early mortality in population data. Maternal nutritional deficiencies, such as inadequate iron, folate, or overall caloric intake, exacerbate perinatal risks by promoting , fetal growth restriction, and , though direct causal links to mortality are mediated by these intermediates and strongest in contexts of severe undernutrition. In contrast, moderate during does not increase perinatal mortality and may mitigate risks from other factors by reducing gestational complications, underscoring inactivity as a potential indirect contributor when compounded with or poor diet.

Socioeconomic and Environmental Influences

Low (SES), encompassing factors such as household , parental , and wealth, consistently correlates with elevated perinatal mortality rates across diverse populations. In a multinational study involving over 100,000 pregnancies, women classified in low SES categories—based on assets, housing quality, and access—faced significantly higher risks of (adjusted odds ratio approximately 1.5-2.0) and perinatal mortality compared to higher SES counterparts, even after adjusting for obstetric factors. Similarly, , higher household levels were linked to lower rates (e.g., a 10% increase in associated with 1-2 fewer stillbirths per 1,000 births) and reduced early neonatal deaths, reflecting improved access to prenatal monitoring and interventions. These patterns persist globally, with during pregnancy independently raising risks for , , and subsequent neonatal death through mechanisms like inadequate nutrition and delayed medical care. Maternal and paternal education levels further mediate these disparities, with lower attainment strongly predicting higher neonatal mortality. For instance, in population-based analyses from low-resource settings, neonates born to mothers with no formal or only primary schooling experienced 1.5- to 2-fold higher mortality rates than those with secondary or higher education, attributable in part to reduced and utilization of antenatal services. In regions like Tigray, , children from households in the lowest wealth quintiles—proxied by ownership of durable goods and living standards—had perinatal mortality rates up to 50% higher than wealthier groups, underscoring the role of economic constraints in limiting preventive care. Such inequalities often exhibit a effect, where incremental improvements in SES yield proportional declines in risk, though residual disparities remain after accounting for confounders like maternal age and parity. Environmental exposures, including ambient and extreme heat, independently contribute to perinatal mortality by impairing fetal development and increasing vulnerability during labor and early neonatal periods. Cohort studies have demonstrated that prenatal exposure to fine particulate matter (PM2.5) from reduces by 10-20 grams per 10 μg/m³ increment, heightening risks for and neonatal death through and inflammation. In utero exposure to extreme heat—defined as temperatures exceeding local 95th percentiles—has been associated with a 0.1-0.3% increase in neonatal mortality per degree Celsius rise, as evidenced by analyses of over 55 million U.S. births from 1997-2018, likely via , preterm , and cardiorespiratory stress on the . Broader chemical contaminants in air, water, and soil, such as and endocrine disruptors, further exacerbate these outcomes by disrupting maternal and fetal growth, with effects persisting across income levels but disproportionately burdening low-SES communities with higher exposure profiles. Climate-driven changes amplifying these exposures pose emerging threats, particularly in tropical and urbanizing regions where adaptive infrastructure lags.

Measurement and Surveillance

Rate Calculation Methods

The perinatal mortality rate (PNMR) is calculated as the number of perinatal deaths—comprising late fetal deaths (stillbirths) and early neonatal deaths—divided by the number of total births (live births plus stillbirths), multiplied by 1,000 to yield deaths per 1,000 births. This formula standardizes reporting for international comparisons, though exact thresholds for inclusion vary. The World Health Organization (WHO) defines stillbirths as fetal deaths at or after 22 completed weeks of gestation (or ≥500 grams birthweight if gestation is unknown), paired with early neonatal deaths occurring within the first 7 days of life. In the United States, the Centers for Disease Control and Prevention (CDC) employs a broader threshold under Definition III, incorporating fetal deaths at 20 weeks of or more alongside infant deaths under 7 days, with the rate computed per 1,000 live births plus qualifying fetal deaths. This approach, updated in vital statistics reporting as of 2025, aims to capture more events but can inflate rates relative to stricter gestational cutoffs like 28 weeks used in some European countries or by the (OECD). Alternative weight-based criteria, such as fetal deaths ≥400 grams (used in some national registries like New Zealand's Perinatal and Maternal Mortality Review Committee), provide flexibility where gestational dating is unreliable, but they risk inconsistencies in low-resource settings. Denominator variations further complicate cross-country analysis: while total births is preferred for inclusivity, some jurisdictions report per live births alone, underestimating rates by excluding stillbirths from the base. These definitional differences, rooted in registration laws and data availability, necessitate caution in global benchmarking, as evidenced by studies showing up to 30% rate disparities attributable to methodological heterogeneity rather than true epidemiological variance.

Data Collection Challenges and Standardization Efforts

Variations in definitions of perinatal mortality across countries pose significant challenges to data comparability. The (WHO) recommends defining as fetal death at or after 28 completed weeks of or weighing 1,000 grams or more, while many high-income countries, including the , include fetal deaths from 20 weeks, leading to inflated rates in comparative analyses. Discrepancies in gestational age thresholds for early neonatal deaths and borderline viability cases (e.g., 22-23 weeks) further exacerbate inconsistencies, with reporting practices varying widely; for instance, 18 of 30 European regions showed substantial differences in periviable birth documentation. Underreporting remains prevalent, particularly in low- and middle-income countries, due to incomplete vital registration systems, cultural stigmas around disclosure, and resource constraints in humanitarian settings. Household surveys have revealed omission rates and misclassifications in routine facility data, limiting the utility of national statistics for global monitoring. In high-income contexts like the , gaps in fetal death certificates, missing maternal demographics, and coding errors contribute to incomplete datasets, hindering trend analysis. To address these issues, the WHO has promoted the , Perinatal Mortality (ICD-PM) extension of , providing standardized coding for causes of stillbirths and neonatal deaths to enhance attribution consistency and data interpretation. The transition to includes updated guidance for uniform reporting of perinatal events, emphasizing and criteria. Global initiatives, such as Maternal and Perinatal Death Surveillance and Response (MPDSR), encourage facility-based audits and community reporting to identify gaps, though implementation varies by context. In the United States, the shifted primary perinatal mortality measures in 2021 to align with international standards, incorporating fetal deaths from 20 weeks alongside early neonatal deaths under 7 days. These efforts aim to reduce systematic biases in cross-national comparisons, though persistent local adaptations underscore ongoing needs for harmonized protocols.

Prevention and Management Strategies

Antenatal Screening and Interventions

Antenatal screening encompasses routine prenatal evaluations, including ultrasound imaging, maternal serum screening for chromosomal anomalies, and tests for , , and , aimed at identifying fetal and maternal risks that contribute to perinatal mortality. Systematic reviews of randomized trials indicate that comprehensive antenatal care packages, incorporating evidence-based screenings, can reduce and neonatal death rates, with one estimating an 18% in stillbirth through strategies like prevention and nutritional support. However, the impact varies by context; in low- and middle-income settings, adequate antenatal visits—defined as four or more—correlate with a 79% lower likelihood of adverse perinatal outcomes compared to fewer visits, primarily through early detection and management of conditions like and . Ultrasound screening, a cornerstone of antenatal assessment, detects fetal growth restriction, congenital anomalies, and placental issues, but evidence for routine use in low-risk pregnancies is limited regarding perinatal mortality reduction. A 2020 systematic review and of trials involving over 50,000 low-risk women found no significant decrease in perinatal death rates with routine third-trimester compared to serial measurements (risk ratio 0.86, 95% CI 0.28-2.66). Similarly, the 1993 trial, involving 15,151 low-risk pregnancies, showed no improvement in perinatal outcomes from screening versus selective use based on clinical judgment. In contrast, targeted Doppler in high-risk cases, such as suspected growth restriction, identifies fetuses at elevated risk of adverse outcomes, enabling interventions like early delivery, though broad application requires resource-appropriate implementation to avoid overuse without mortality benefits. Infection screening and treatment represent high-impact interventions, particularly in endemic areas. Antenatal testing and penicillin treatment for prevent up to 82% of associated perinatal deaths, as modeled in Lives Saved Tool analyses incorporating trial data from syphilis-endemic regions.00355-0/abstract) Similarly, screening for and prompt antimalarial therapy in reduces stillbirth risk by addressing placental sequestration, with meta-analyses confirming efficacy in . For gestational diabetes, universal screening via glucose challenge tests followed by metformin or insulin management lowers composite neonatal morbidity and mortality risks, including perinatal death, by mitigating macrosomia and . Nutritional and pharmacological interventions triggered by screening further target modifiable risks. Low-dose aspirin (81-150 mg daily) initiated before 16 weeks for women screened at high risk—via history, , and biomarkers—reduces and by 14-20%, per meta-analyses of over 40,000 participants, through improved placental . Progesterone supplementation, indicated after screening for short cervical length (<25 mm) via transvaginal , prevents preterm labor and associated neonatal deaths in singleton pregnancies with prior history ( 0.50 for perinatal death). Multiple supplementation, recommended following screening, decreases and perinatal mortality by 10-12% compared to iron-folic acid alone, based on pooled trial data from diverse settings.00355-0/abstract) Despite these benefits, Cochrane reviews highlight that many antenatal strategies lack robust evidence for direct prevention, underscoring the need for context-specific application to avoid ineffective .

Intrapartum and Perinatal Care Protocols

Intrapartum care protocols prioritize vigilant monitoring of labor progression and fetal status to avert hypoxia, , and other complications implicated in approximately 50% of stillbirths occurring during labor in low- and middle-income countries. The (WHO) endorses the partograph as a simple tool for plotting , fetal heart rate, and maternal against time, enabling early detection of abnormal labor patterns that necessitate interventions like oxytocin augmentation or operative delivery; implementation has correlated with decreased durations exceeding 12 hours, a known for fetal distress. Fetal heart rate (FHR) surveillance constitutes a cornerstone, with intermittent recommended for low-risk pregnancies every 15-30 minutes in the first stage of labor and more frequently thereafter, while electronic fetal monitoring (EFM) is advised for high-risk cases to identify category II or III tracings signaling potential or compromise, prompting actions such as maternal repositioning, oxygen administration, or cesarean section. American College of Obstetricians and Gynecologists (ACOG) guidelines emphasize standardized interpretation of FHR patterns, noting that while continuous EFM reduces neonatal seizures by up to 50% in randomized trials, it does not consistently lower overall perinatal mortality or rates in low-risk cohorts, underscoring the need for adjunctive clinical judgment over reliance on tracing alone. Aseptic techniques, including hand hygiene and perineal disinfection, form essential components to curb intrapartum infections, which contribute to 10-20% of perinatal deaths globally; WHO protocols advocate for delayed clamping by at least 1 minute in vigorous term newborns to enhance placental transfusion and reduce anemia-related mortality risks. In resource-constrained settings, integrated bundles such as Tanzania's Safer Births initiative—encompassing simulation training for , newborn , and essential newborn care—yielded a 32% reduction in intrapartum stillbirths and a 15% drop in early neonatal mortality in cluster-randomized trials conducted through 2023. Perinatal care protocols extend into the immediate , focusing on rapid newborn assessment and to address birth , responsible for 23% of neonatal deaths worldwide. The American Heart Association's 2025 guidelines delineate a stepwise : initial drying and stimulation within 30 seconds for non-vigorous infants, followed by positive pressure ventilation at 40-60 breaths per minute if remains below 100 bpm after 30 seconds, with chest compressions initiated for rates under 60 bpm; these measures, when protocolized, have reduced asphyxia-specific mortality by 47% in trained cohorts. Programs like Helping Babies Breathe, emphasizing basic bag-mask ventilation training, demonstrated a 30% decline in intrapartum-related neonatal deaths in Nepalese facilities from 2013 to 2015, with sustained effects in subsequent meta-analyses across low-resource sites. Adherence to these evidence-based steps, rather than unstandardized practices, directly correlates with improved Apgar scores and survival, though gaps in skilled attendance persist, contributing to 2.4 million annual perinatal deaths amenable to such interventions.

Neonatal Resuscitation and Support

Neonatal resuscitation encompasses immediate interventions to support vital functions in newborns who fail to establish effective respiration and circulation post-delivery, addressing a primary cause of early neonatal deaths within perinatal mortality. Approximately 10% of term newborns require some form of assistance at birth, with asphyxia-related events contributing to up to 30% of neonatal deaths globally, particularly in low-resource settings where basic measures like bag-and-mask ventilation can avert a substantial portion. Standard protocols, such as those from the (NRP) developed by the and , emphasize a stepwise approach starting with based on factors like or meconium-stained . Updated guidelines from 2025 highlight the use of 21% oxygen for initial resuscitation in term infants to minimize while ensuring adequate oxygenation. The initial steps involve rapid assessment within the first minute: drying the infant, providing warmth, positioning the head to open the airway, and stimulating crying through gentle rubbing. If the remains below 100 beats per minute after 30 seconds, positive pressure ventilation (PPV) via a self-inflating and at 40-60 breaths per minute is initiated, with chest compressions added if the rate falls below 60 beats per minute using a 3:1 ratio coordinated with ventilations. Advanced support includes endotracheal for ineffective PPV, epinephrine administration for persistent , and volume expansion for , guided by tools like or ECG for monitoring when available. In very infants, adherence to these escalated levels has been linked to reduced mortality and morbidities such as . Training programs like NRP and Helping Babies Breathe have demonstrated effectiveness in improving outcomes; a of neonatal resuscitation trainings reported a 32% relative reduction in perinatal mortality (RR 0.68, 95% CI 0.52-0.88), though effects on overall neonatal mortality were less consistent due to factors like prematurity. Post-training assessments show significant gains in provider knowledge and skills, with hybrid simulations enhancing retention in resource-limited areas. In low-resource settings, guidelines from 2012 prioritize basic resuscitation—focusing on ventilation without advanced equipment—to target the 6 million annual cases needing intervention, potentially preventing 30% of intrapartum-related deaths where skilled attendants are scarce. Supportive care following resuscitation includes thermal stabilization using skin-to-skin contact or radiant warmers, glucose monitoring to prevent , and transfer to neonatal intensive care for ongoing ventilation or in preterm cases. Effective requires multidisciplinary teams and regular simulations, as performance declines without reinforcement, underscoring the need for sustained to translate protocols into mortality reductions. Challenges persist in scaling these interventions globally, where facility births with trained providers remain uneven, but evidence supports their causal role in averting asphyxia-driven perinatal losses when prioritized.

Disparities and Equity Issues

Racial and Ethnic Disparities

In the , perinatal mortality rates exhibit marked racial and ethnic disparities, with non-Hispanic mothers consistently experiencing the highest rates. For 2022, the CDC reported a rate of 15.05 perinatal deaths per 1,000 live births plus fetal deaths for non-Hispanic mothers, more than twice the 6.70 rate for non-Hispanic White mothers. Non-Hispanic Asian mothers had the lowest rate at 5.71 per 1,000, while mothers recorded 7.26, non-Hispanic American Indian or Alaska Native mothers 10.92, and non-Hispanic Native Hawaiian or Other mothers 13.69 per 1,000. These disparities showed no significant change in 2023, except for a 4% increase among mothers to 7.57 per 1,000.
Maternal Race/Ethnicity (Non-Hispanic unless noted)2022 Rate (per 1,000)2023 Rate (per 1,000)
15.0515.04
Native Hawaiian/Other Pacific Islander13.6914.09
American Indian/Alaska Native10.9210.63
7.267.57
6.706.76
Asian5.716.03
Such patterns align with broader trends in , where non-Hispanic Black infants face rates over twice those of White infants (10.9 vs. 4.5 per 1,000 live births in recent years), driven primarily by elevated risks of and low birthweight-related complications. occurs approximately 50% more frequently among , contributing disproportionately to perinatal losses across gestational ages.01869-7/fulltext) Explanations for these disparities remain debated, with empirical evidence indicating multifactorial origins. Socioeconomic factors, healthcare access, and explain part of the gap, yet studies adjusting for these variables find persistent differences, particularly in preterm delivery risks, pointing to potential interplay of environmental exposures and heritable factors. For instance, racial variances in at birth show both genetic and environmental components, with Black-White disparities in prematurity-related mortality exceeding those for congenital anomalies, which are less environmentally modifiable. CDC data, derived from vital statistics, provide robust empirical tracking but may undercount due to reporting inconsistencies; peer-reviewed analyses corroborate the trends while cautioning against overattribution to any single cause without causal evidence. Internationally, similar ethnic gradients appear in high-income settings, such as elevated stillbirth rates among Black African-origin women in , though data are sparser and often confounded by migration status. exhibits a clear inverse gradient with perinatal mortality rates, where lower household correlates with elevated risks of and early neonatal death. , analysis of over 25 million births from 1998 to 2017 revealed a perinatal mortality rate of 5.1 per 1,000 total births, declining progressively from 6.9 per 1,000 in the lowest quintile to 4.0 per 1,000 in the highest, after adjusting for maternal age, race, and parity. This pattern persists even in high-income settings, driven by factors such as reduced access to prenatal screening and specialized care among lower- groups. Similarly, in eastern , socioeconomic inequalities result in neonatal mortality rates up to twice as high among particularly vulnerable tribal populations compared to non-tribal groups, reflecting disparities in maternal and service uptake. Access to healthcare infrastructure amplifies these gaps, particularly in low- and middle-income countries where perinatal mortality often exceeds 30 per 1,000 births due to shortages of skilled birth attendants and emergency obstetric services. Neonatal death rates in such settings range from 8 per 1,000 in upper-middle-income nations like to 41 per 1,000 in lower-income countries like , with over half of deaths occurring in term or normal-weight infants amenable to timely interventions. Barriers including geographic isolation, inadequate transportation, and under-resourced facilities prevent progression through the continuum of care, from antenatal visits to intrapartum management. In the U.S., payment source for delivery—proxying insurance and access—shows higher infant mortality among publicly insured or uninsured births, linked to delayed and lower maternal socioeconomic indicators. These disparities underscore causal links between resource scarcity and outcomes, independent of inherent biological risks; for instance, income inequality within regions positively associates with neonatal mortality in the , suggesting broader systemic failures in equitable service distribution. Interventions targeting access, such as expanded programs, have demonstrated potential to narrow gaps, though persistent structural inequalities in and income continue to hinder uniform reductions. Maternal education below 12 years, often intertwined with low , sustains a 135% higher risk in affected groups.

Controversies and Critical Perspectives

Debates on Causal Attribution

Attributing causes to perinatal mortality remains contentious due to the multifactorial involving interacting biological, obstetric, and environmental pathways, often complicating precise identification of primary versus contributory factors. Diagnostic evaluations frequently reveal discrepancies, with expert panels reclassifying up to 37% of stillbirths and neonatal deaths differently from initial clinical assessments, such as shifting attributions from respiratory distress syndrome to birth . In the PURPOSe study of over 1,000 cases, fetal —often stemming from placental malperfusion—was identified as the leading cause in 81.6% of stillbirths, contrasting with prior emphases on anomalies or unexplained cases, highlighting how incomplete autopsies or limited placental contribute to underrecognition of vascular pathologies. A core debate centers on biomedical determinism versus broader social determinants, where empirical data underscore direct physiological risks like and hypoxia as proximal causes, yet some analyses argue that perinatal metrics obscure socioeconomic influences on access to care. For instance, while infections and prematurity account for substantial neonatal deaths—comprising 40.6% hypoxia-related and 48.7% immaturity-linked in cohort studies—attribution debates question whether in low-resource settings represent true causal lapses or proxies for systemic inequities, with evidence showing 25.2% of late perinatal deaths tied to birth defects or hypoxia irrespective of setting. Critics of overemphasizing social factors note that adjusting for confounders like fails to fully resolve associations with mortality, suggesting unmeasured biological intermediates like chorioamnionitis persist as independent drivers. Maternal modifiable risks, particularly obesity and advanced age, fuel ongoing contention regarding personal versus structural causation. Pre-pregnancy elevates stillbirth and neonatal death risks in a dose-dependent manner, with meta-analyses reporting odds ratios increasing from 1.5 for to over 2.0 for severe obesity, mediated partly by earlier delivery and complications like . Similarly, maternal age over 35 correlates with heightened odds, equivalent to post-term risks in younger women, yet debates arise over whether these reflect inherent physiological declines—such as reduced placental efficiency—or are confounded by lifestyle aggregates like and comorbidities. Empirical trends link rising U.S. perinatal mortality since 2017 partly to obesity prevalence, challenging attributions that prioritize healthcare disparities over these quantifiable biological contributors. Intervention-related attributions, such as elective , exemplify causal ambiguity, with trials like ARRIVE indicating 39-week induction halves perinatal adverse outcomes without elevating cesarean rates in low-risk nulliparas, yet observational data debate iatrogenic harms like increased or trauma in non-indicated cases. Post-term inductions demonstrably cut stillbirths from 2.8 to 0.9 per 1,000 beyond 41 weeks, but controversies persist on generalizing to earlier gestations, where potential for failed induction and emergency cesareans may offset benefits, underscoring tensions between preventive intent and unintended physiological disruptions. Overall, these debates underscore the need for standardized, autopsy-inclusive protocols to disentangle causal chains, as inconsistent classifications—evident in ICD revisions—impede evidence-based attribution. In developed countries, the average age at first birth has risen significantly over recent decades, reflecting social shifts toward prolonged education, career prioritization, and delayed family formation among women. In the United States, this metric increased from 21 years in 1970 to 26 years by the late 2010s. Comparable upward trends appear in Europe, where countries like Sweden now report averages exceeding 31 years for first-time mothers. These patterns stem from expanded access to contraception, higher female workforce participation, and cultural emphases on individual achievement before parenthood, resulting in a growing proportion of pregnancies among women classified as advanced maternal age (AMA, ≥35 years). Biologically, AMA elevates perinatal mortality risks through mechanisms such as increased chromosomal in oocytes, , and hypertensive disorders, independent of medical advancements. A of over 22,000 singleton pregnancies in (2011–2019) found women with AMA had 1.8 times higher adjusted odds of perinatal mortality (95% CI: 1.3–2.3), alongside 1.6 times higher odds of (95% CI: 1.4–1.7) and 1.3 times higher odds of (95% CI: 1.2–1.4)—all key contributors to fetal and neonatal death—compared to women under 30. Similar associations hold in Western populations; for instance, maternal age over 40 correlates with elevated early neonatal mortality risk. These effects persist even after adjusting for confounders like parity and comorbidities, underscoring a causal link rooted in reproductive aging rather than solely socioeconomic factors. Concomitant trends include rising use of assisted reproductive technologies (), often necessitated by AMA-related , which introduces further perinatal hazards. IVF-conceived pregnancies exhibit higher rates than spontaneous ones, attributable to underlying subfertility, manipulation, and elevated multiple gestation risks leading to prematurity.00293-4/fulltext) While some data indicate ART may lower very early perinatal deaths (<28 weeks) through intensive monitoring, overall perinatal mortality remains increased due to these complications. In aggregate, such social patterns partially offset perinatal care improvements, contributing to stable or modestly rising rates in high-AMA demographics despite global declines.

References

  1. https://dhsprogram.com/data/Guide-to-DHS-Statistics/Perinatal_Mortality.htm
  2. https://www.uptodate.com/contents/perinatal-mortality
  3. https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-022-04596-0
  4. https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0001612
  5. https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-015-0472-9
  6. https://www.cdc.gov/nchs/products/databriefs/db530.htm
  7. https://gh.bmj.com/content/8/4/e011253
  8. https://pmc.ncbi.nlm.nih.gov/articles/PMC7193071/
  9. https://gateway.euro.who.int/en/indicators/hfa_84-1170-perinatal-deaths-per-1000-births/
  10. https://www.cdc.gov/nchs/products/databriefs/db489.htm
  11. https://platform.who.int/mortality/themes/theme-details/topics/topic-details/MDB/perinatal-conditions
  12. https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.15794
  13. https://www.sciencedirect.com/topics/medicine-and-dentistry/perinatal-period
  14. https://www.data4impactproject.org/prh/womens-health/newborn-health/perinatal-mortality-rate-pmr/
  15. https://www.cdc.gov/nchs/data/nvsr/nvsr74/nvsr74-05.pdf
  16. https://www.sciencedirect.com/science/article/pii/S2666606525001634
  17. https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-016-0993-x
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC5488116/
  19. https://www.bmj.com/content/344/bmj.e746
  20. https://www.cdc.gov/global-reproductive-health/php/perinatal-death-surveillance-response/index.html
  21. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1434380/full
  22. https://jogh.org/2022/jogh-12-04069/
  23. https://data.unicef.org/topic/child-survival/stillbirths/
  24. https://data.unicef.org/topic/child-survival/neonatal-mortality/
  25. https://www.who.int/news-room/fact-sheets/detail/newborn-mortality
  26. https://pubmed.ncbi.nlm.nih.gov/31097275/
  27. https://data.worldbank.org/indicator/SH.DYN.NMRT
  28. https://www.cdc.gov/nchs/data/databriefs/db489.pdf
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC2647461/
  30. https://data.unicef.org/resources/never-forgotten-stillbirth-estimates-report/
  31. https://data.who.int/indicators/i/E3CAF2B/A4C49D3
  32. https://www.sciencedirect.com/science/article/abs/pii/S1751721410001545
  33. https://pubmed.ncbi.nlm.nih.gov/34454675/
  34. https://data.unicef.org/resources/global-regional-and-national-estimates-and-trends-in-stillbirths/
  35. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X%2823%2900125-0/fulltext
  36. https://obgyn.onlinelibrary.wiley.com/doi/full/10.1002/uog.27543
  37. https://worldpopulationreview.com/country-rankings/neonatal-mortality-rate-by-country
  38. https://www.kff.org/racial-equity-and-health-policy/racial-disparities-in-maternal-and-infant-health-current-status-and-efforts-to-address-them/
  39. https://jech.bmj.com/content/65/8/696
  40. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2785667
  41. https://healthynewbornnetwork.org/resource/2023/never-forgotten-the-situation-of-stillbirth-around-the-globe/
  42. https://www.nature.com/articles/s41598-024-65985-3
  43. https://pubmed.ncbi.nlm.nih.gov/9758260/
  44. https://jamanetwork.com/journals/jama/fullarticle/1104720
  45. https://www.ncbi.nlm.nih.gov/books/NBK557533/
  46. https://www.ncbi.nlm.nih.gov/books/NBK563171/
  47. https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.18158?af=R
  48. https://www.cureus.com/articles/158770-placental-pathology-and-maternal-risk-factors-for-stillbirth-a-case-control-study
  49. https://obgyn.onlinelibrary.wiley.com/doi/10.1111/tog.12708
  50. https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06588-8
  51. https://journals.sagepub.com/doi/full/10.1177/20503121231201282
  52. https://pubmed.ncbi.nlm.nih.gov/24356234/
  53. https://publications.aap.org/pediatrics/article/133/5/863/32718/Maternal-Obesity-and-Infant-Mortality-A-Meta
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC9119174/
  55. https://pmc.ncbi.nlm.nih.gov/articles/PMC4682577/
  56. https://pmc.ncbi.nlm.nih.gov/articles/PMC4347876/
  57. https://diabetesjournals.org/care/article/48/11/1896/163368/Maternal-Diabetes-Fetal-Growth-and-Stillbirth-Risk
  58. https://www.nature.com/articles/s41372-019-0516-5
  59. https://pubmed.ncbi.nlm.nih.gov/14600573/
  60. https://academic.oup.com/cid/article/73/8/1355/6224393
  61. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X%2823%2900468-0/fulltext
  62. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0089419
  63. https://pmc.ncbi.nlm.nih.gov/articles/PMC6349478/
  64. https://pmc.ncbi.nlm.nih.gov/articles/PMC11863858/
  65. https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0002261
  66. https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-017-1636-6
  67. https://www.merckmanuals.com/home/women-s-health-issues/complications-of-pregnancy/maternal-mortality-and-perinatal-mortality
  68. https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2024.1335926/full
  69. https://pmc.ncbi.nlm.nih.gov/articles/PMC3918931/
  70. https://www.nature.com/articles/s41598-021-80968-4
  71. https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-017-1420-7
  72. https://pmc.ncbi.nlm.nih.gov/articles/PMC3511893/
  73. https://minorityhealth.hhs.gov/infant-health-and-mortality-and-blackafrican-americans
  74. https://pmc.ncbi.nlm.nih.gov/articles/PMC10998184/
  75. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2822%2901191-6/fulltext
  76. https://www.nature.com/articles/s41598-019-38583-x
  77. https://www.nature.com/articles/s41598-024-61867-w
  78. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/perinatal-mortality
  79. https://pmc.ncbi.nlm.nih.gov/articles/PMC4945701/
  80. https://pubmed.ncbi.nlm.nih.gov/27370789/
  81. https://www.sciencedirect.com/science/article/abs/pii/S0378378207001247
  82. https://pubmed.ncbi.nlm.nih.gov/24709933/
  83. https://mdedge.com/endocrinology/article/253034/obstetrics/maternal-obesity-promotes-risk-perinatal-death
  84. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0264565
  85. https://www.cuimc.columbia.edu/news/stillbirth-risk-triples-when-women-smoke-and-drink-during-pregnancy
  86. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2783302
  87. https://academic.oup.com/ijnp/article/28/8/pyaf046/8195504
  88. https://www.nature.com/articles/pr19981519
  89. https://www.sciencedirect.com/science/article/pii/S0022316622159341
  90. https://pmc.ncbi.nlm.nih.gov/articles/PMC9772147/
  91. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0272712
  92. https://pmc.ncbi.nlm.nih.gov/articles/PMC2528810/
  93. https://www.sciencedirect.com/science/article/pii/S2213398421001093
  94. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-019-7642-z
  95. https://equityhealthj.biomedcentral.com/articles/10.1186/s12939-022-01655-y
  96. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797628
  97. https://academic.oup.com/pnasnexus/article/4/8/pgaf240/8236461
  98. https://pmc.ncbi.nlm.nih.gov/articles/PMC7891208/
  99. https://www.nature.com/articles/s41591-024-03395-8
  100. https://www.sciencedirect.com/topics/medicine-and-dentistry/perinatal-mortality
  101. https://stats.oecd.org/wbos/fileview2.aspx?IDFile=f4ac27e3-007d-4800-8d01-e70f6a6ed7f0
  102. https://www.who.int/data/gho/indicator-metadata-registry/imr-details/67
  103. https://www.ncbi.nlm.nih.gov/books/NBK615316/
  104. https://www.hqsc.govt.nz/assets/Our-work/Mortality-review-committee/PMMRC/Publications-resources/methods-and-definitions-pmmrc-14th-final.pdf
  105. https://pmc.ncbi.nlm.nih.gov/articles/PMC4560894/
  106. https://www.cdc.gov/nchs/data/series/sr_20/sr20_026.pdf
  107. https://www.who.int/teams/maternal-newborn-child-adolescent-health-and-ageing/maternal-health/maternal-and-perinatal-death-surveillance-and-response
  108. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822061
  109. https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-015-0430-8
  110. https://conflictandhealth.biomedcentral.com/articles/10.1186/s13031-024-00607-3
  111. https://sph.emory.edu/news/data-prevent-maternal-infant-deaths
  112. https://www.who.int/docs/default-source/mca-documents/maternal-nb/icd-pm.pdf?Status=Master&sfvrsn=9470cccf_2
  113. https://pmc.ncbi.nlm.nih.gov/articles/PMC8078228/
  114. https://www.cureus.com/articles/214304-the-effectiveness-of-adequate-antenatal-care-in-reducing-adverse-perinatal-outcomes-evidence-from-a-low--or-middle-income-country
  115. https://pubmed.ncbi.nlm.nih.gov/33345941/
  116. https://www.nejm.org/doi/full/10.1056/NEJM199309163291201
  117. https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-025-07586-0
  118. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009599.pub2/full
  119. https://www.who.int/publications/i/item/9789241550215
  120. https://www.acog.org/clinical/clinical-guidance/clinical-practice-guideline/articles/2025/10/intrapartum-fetal-heart-rate-monitoring-interpretation-and-management
  121. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/02/approaches-to-limit-intervention-during-labor-and-birth
  122. https://www.nejm.org/doi/full/10.1056/NEJMoa2406295
  123. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001367
  124. https://publications.aap.org/pediatrics/article/137/6/e20150117/52430/Reducing-Perinatal-Mortality-in-Nepal-Using
  125. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000902
  126. https://gh.bmj.com/content/5/9/e002268
  127. https://www.aafp.org/pubs/afp/issues/2011/0415/p911.html
  128. https://pubmed.ncbi.nlm.nih.gov/19815203/
  129. https://www.aafp.org/pubs/afp/issues/2021/1000/p425.html
  130. https://www.nature.com/articles/s41598-021-88561-5
  131. https://karger.com/neo/article/122/Suppl.%25201/52/916454/Effectiveness-of-Neonatal-Resuscitation-Training
  132. https://pmc.ncbi.nlm.nih.gov/articles/PMC11875418/
  133. https://www.who.int/publications/i/item/9789241503693
  134. https://publications.aap.org/pediatrics/article/146/1_MeetingAbstract/338/4391/Impact-of-Repeat-Simulated-Neonatal-Resuscitation
  135. https://pmc.ncbi.nlm.nih.gov/articles/PMC5862177/
  136. https://bmjpaedsopen.bmj.com/content/1/1/e000183
  137. https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-022-05100-4
  138. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012391
  139. https://pmc.ncbi.nlm.nih.gov/articles/PMC1913086/
  140. https://www.cdc.gov/nchs/products/databriefs/db371.htm
  141. https://pmc.ncbi.nlm.nih.gov/articles/PMC8564582/
  142. https://pmc.ncbi.nlm.nih.gov/articles/PMC4337792/
  143. https://www.sciencedirect.com/science/article/abs/pii/S0091743520303923
  144. https://equityhealthj.biomedcentral.com/articles/10.1186/s12939-024-02157-9
  145. https://www.mdpi.com/2227-9067/9/3/394
  146. https://ej-med.org/index.php/ejmed/article/view/1309
  147. https://obgyn.onlinelibrary.wiley.com/doi/10.1002/pd.6754
  148. https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.17635
  149. https://journalofethics.ama-assn.org/article/who-counts-what-counts-place-and-limits-perinatal-mortality-measures/2018-03
  150. https://pmc.ncbi.nlm.nih.gov/articles/PMC12020399/
  151. https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0000812
  152. https://pubmed.ncbi.nlm.nih.gov/39788539/
  153. https://www.nejm.org/doi/full/10.1056/NEJMoa1800566
  154. https://pmc.ncbi.nlm.nih.gov/articles/PMC1230266
  155. https://pmc.ncbi.nlm.nih.gov/articles/PMC11448375/
  156. https://www.nytimes.com/interactive/2018/08/04/upshot/up-birth-age-gap.html
  157. https://blog.myheritage.com/2025/05/becoming-mom-how-the-age-of-first-time-motherhood-has-evolved-around-the-world/
  158. https://pmc.ncbi.nlm.nih.gov/articles/PMC9233367/
  159. https://jamanetwork.com/journals/jama/fullarticle/399272
  160. https://pubmed.ncbi.nlm.nih.gov/34282572/
  161. https://pubmed.ncbi.nlm.nih.gov/35551699/
Add your contribution
Related Hubs
User Avatar
No comments yet.